RIAS
TLSI icon

Rachor Investment Advisory Services’s TriSalus Life Sciences TLSI Stock Holding History

Rachor Investment Advisory Services’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-51
Closed -$204 – 405
2026
Q1 		$204 Hold
51
– – ﹤0.01% 439
2025
Q4 		$356 Buy
+51
New +$286 ﹤0.01% 364

Other funds holding TLSI

WPC
White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CWM
Connecticut Wealth Management Farmington, Connecticut $2.7B AUM 21.91% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Rachor Investment Advisory Services's TLSI Position: Q2 2026 in Review

Rachor Investment Advisory Services sold out of TriSalus Life Sciences (TLSI) in Q2 2026, closing a stake of 51 shares — an estimated $204 sold.

Rachor Investment Advisory Services first reported a position in TLSI in Q4 2025 and held it in 2 quarters. The position peaked at $356 in Q4 2025. 25 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

  • Rachor Investment Advisory Services reported no remaining TriSalus Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Rachor Investment Advisory Services sold 51 TriSalus Life Sciences shares in Q2 2026, an estimated $204.
  • Rachor Investment Advisory Services first reported a position in TriSalus Life Sciences in Q4 2025 and held it in 2 quarters.
  • Rachor Investment Advisory Services's TriSalus Life Sciences position peaked at $356 in Q4 2025.
  • 25 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on Rachor Investment Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.